Somaxon Presents Pharmacological Data on Doxepin at the 21st European … | Home | Sleeping Pill Safety

September 3, 2008

Sepracor announces results of Phase IV study of drug for insomnia treatment

The double-blind, randomised safety and efficacy study included 388 elderly patients who were administered either LUNESTA 2.0 mg or placebo nightly.


From Insomnia News

This entry was posted on Wednesday, September 3rd, 2008 at 4:54 pm and is filed under Insomnia. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.